NetworkNewsBreaks Archive - Page 1931 of 1938

TuesdayOct 11, 2016 11:12 am

Biostar Pharmaceuticals, Inc. (BSPM) to Launch “Easy Breathing” Product in the People’s Republic of China, Shares Spike 16%

Shares of Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) surged more than 16% in Tuesday’s morning trade after the manufacturer and marketer of pharmaceutical and health supplement products in China announced the upcoming launch of its "Easy Breathing" product for the treatment of rhinitis and sinusitis. The product will be manufactured, distributed and sold in the People’s Republic of China, where the company is based. Sales will commence in November 2016. Rhinitis is irritation and inflammation of the mucous membrane inside the nose. Sinusitis is an inflammation or swelling of the tissue lining the sinuses. To view the full press release, visit:…

MondayOct 10, 2016 12:23 pm

OurPet’s Company (OPCO) Partners with Paulee Cleantec Ltd. to Create Eco-Friendly Waste Management Solutions

OurPet’s Company (OTCQX: OPCO) today announced that it has teamed up with Israel-based Paulee Cleantec, an international leader in eco-friendly solutions for the management of human and animal waste, calling the new partnership a “viable catalyst of major innovative solutions to the environmental concerns of pet waste management.” Paulee Cleantec has developed a patented waste system to rapidly convert animal feces into an odor-free ash fertilizer, thereby reducing the damaging impact of pet waste management on the environment. The partnership will leverage both companies’ innovations to commercialize an initial, portable dog waste product, as well as to apply the technology…

MondayOct 10, 2016 11:58 am

CytRx Corporation (CYTR) Presents Interim Clinical Trial Results for Aldoxorubicin Combination

CytRx (NASDAQ: CYTR) today presented interim results from its ongoing phase 1b/2 trail of aldoxorubicin in combination with ifosfamide/mesna in patients with advanced sarcomas, pushing shares higher in morning trade. At the European Society for Medical Oncology (ESMO) 2016 Congress being held in Copenhagen, Denmark, CytRx reported that: over 25% of sarcoma patients achieved a partial response for the target lesion while 61% had prolonged stable disease; six patients with unresectable tumors achieved greater than 50% tumor shrinkage, allowing some of them to become eligible for surgery; and there were no signs of cardiotoxicity, including in patients that received approximately…

MondayOct 10, 2016 11:57 am

SinglePoint, Inc. (SING) in Final Stages of Uplisting, CEO says on MoneyTV with Donald Baillargeon

SinglePoint (OTC: SING), a full-service mobile technology and marketing provider, was recently featured on MoneyTV, an internationally syndicated television program about “money and what makes it happen.” In the interview, SinglePoint CEO Greg Lambrecht tells host Donald Baillargeon about the company’s ongoing efforts to become a fully reporting company and uplist to the OTCQB Venture Market. SinglePoint has already completed the required Form 10 and hopes to submit it to the U.S. Securities and Exchange Commission and become a fully reporting company “within the next week or so.” To view the full article, visit: http://nnw.fm/y7dFQ About SinglePoint, Inc. SinglePoint, Inc.…

MondayOct 10, 2016 11:56 am

MobileIron, Inc. (MOBL) Boosts Q3 Guidance, Shares Climb

Shares of MobileIron (NASDAQ: MOBL) are trading higher this morning after the stand-alone enterprise mobility management (EMM) provider raised guidance its guidance for the third quarter ended September 30, 2016, and said it is “on track” to be cash flow positive by the fourth quarter. Gross billings for the third quarter of 2016 are expected to be in the range of $46.5 million-$47.5 million, above the company's previous guidance of $43 million-$45 million. MobileIron said it now expects revenues between $41.0 million-$42.0 million, above the previous guidance of $39 million-$41 million. Non-GAAP operating expenses are expected to be at the…

MondayOct 10, 2016 11:55 am

Monaker Group, Inc. (MKGI) Gaining Traction in Industry Set for $169B

Monaker Group (OTCQB: MKGI), a technology-driven travel company focused on the alternative lodging rental (ALR) market, earlier this year launched its Monaker Booking Engine ("MBE") and completed its Application Program Interface ("API") to the MBE. Along with the company’s flagship NextTrip.com platform, the achievements mark the company’s advanced penetration of the ALR market, which industry experts say will reach approximately $169 billion by 2019. To read the full article, visit: http://nnw.fm/gJq4K About Monaker Group Monaker Group is a technology driven Travel Company with multiple divisions and brands, leveraging more than 60 years of operation in leisure travel. Monaker's flagship is…

MondayOct 10, 2016 11:53 am

Net Element, Inc. (NETE) Subsidiary Retained by Market-Leading Courier Service in Kazakhstan

Net Element, Inc. (NASDAQ: NETE) this morning announced that its PayOnline subsidiary has signed an agreement with ExLine, a leading provider of courier and delivery services, freight forwarding and other related services in Kazakhstan in Central Asia, making PayOnline’s payment services available to more than 50,000 of ExLine’s customers. Per the agreement, PayOnline has implemented a custom payment solution which includes an invoice number on the secure payment page and 24/7 customer support. Payments are accepted in Kazakhstan's national currency, Russian rubles, U.S. dollars and euros. To view the full press release, visit: http://nnw.fm/pTy2o About Net Element, Inc. Net Element,…

FridayOct 07, 2016 2:42 pm

Alcobra (ADHD) Issues Update on FDA Communications Regarding MEASURE Study

Alcobra Ltd. (NASDAQ: ADHD), an emerging pharmaceutical firm focused on the development of novel medications to treat cognitive disorders such as Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, announced earlier today that it has received a full clinical hold notice from the U.S. Food and Drug Administration’s Division of Psychiatry Products regarding its phase III clinical study of Metadoxine Extended Release (MDX) for the treatment of ADHD in adult patients. The letter indicates that the FDA hold in in response to electrophysiological neurologic findings in previously submitted long-term animal studies of Metadoxine. The FDA has recommended that Alcobra…

FridayOct 07, 2016 1:14 pm

Idera Pharmaceuticals (IDRA) Prices Public Offering of Common Stock at $2 per Share

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) priced an underwritten public offering of 25 million shares of its common stock at $2.00 per share in a news release issued this morning. Underwriters participating in the offering are granted a 30-day option to purchase up to an additional 3,750,000 shares of common stock, with all shares in the offering being sold by Idera. Gross proceeds from this offering are expected to total roughly $50 million before underwriting discounts and commissions and other offering expenses. The company plans to use the net proceeds from this offering, along with its existing cash and cash equivalents,…

FridayOct 07, 2016 12:55 pm

Frontier Communications (FTR) Offering Free Call Forwarding for South Carolina Customers Affected by Hurricane Matthew

Frontier Communications Corp. (NASDAQ: FTR), a leading provider of communications services, issued a news release earlier today reminding its residential and business customers that they can stay connected with their home or business phones during evacuations related to Hurricane Matthew with the company’s call forwarding feature. Although many of the company’s customers already have access to the feature as part of their bundled services, Frontier is offering all of its South Carolina customers in impacted areas access to its call forwarding feature free of charge for the next 30 days to aid in the ongoing evacuations. “Communications, particularly in uncertain…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks